Thrombin-dependent Incorporation of von Willebrand Factor into a Fibrin Network

被引:32
|
作者
Miszta, Adam [1 ,2 ]
Pelkmans, Leonie [1 ,2 ]
Lindhout, Theo [1 ,2 ]
Krishnamoorthy, Ganeshram [1 ]
de Groot, Philip G. [3 ]
Hemker, Coenraad H. [1 ,2 ]
Heemskerk, Johan W. M. [1 ]
Kelchtermans, Hilde [1 ,2 ]
de Laat, Bas [1 ,2 ]
机构
[1] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6229 EV Maastricht, Netherlands
[2] Synapse BV, NL-6229 EV Maastricht, Netherlands
[3] Univ Med Ctr Utrecht, NL-3584 CX Utrecht, Netherlands
关键词
PLATELET-ADHESION; VONWILLEBRAND-FACTOR; POLYMERIZING FIBRIN; FACTOR-XIII; SHEAR; ELLIPSOMETRY; ACTIVATION; DOMAIN; BLOOD; AGGREGATION;
D O I
10.1074/jbc.M114.591677
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Attachment of platelets from the circulation onto a growing thrombus is a process involving multiple platelet receptors, endothelial matrix components, and coagulation factors. It has been indicated previously that during a transglutaminase reaction activated factor XIII (FXIIIa) covalently cross-links von Willebrand factor (VWF) to polymerizing fibrin. Bound VWF further recruits and activates platelets via interactions with the platelet receptor complex glycoprotein Ib (GPIb). In the present study we found proof for binding of VWF to a fibrin monomer layer during the process of fibrinogen-to-fibrin conversion in the presence of thrombin, arvin, or a snake venom from Crotalus atrox. Using a domain deletion mutant we demonstrated the involvement of the C domains of VWF in this binding. Substantial binding of VWF to fibrin monomers persisted in the presence of the FXIIIa inhibitor K9-DON, illustrating that cross-linking via factor XIII is not essential for this phenomenon and suggesting the identification of a second mechanism through which VWF multimers incorporate into a fibrin network. Under high shear conditions, platelets were shown to adhere to fibrin only if VWF had been incorporated. In conclusion, our experiments show that the C domains of VWF and the E domain of fibrin monomers are involved in the incorporation of VWF during the polymerization of fibrin and that this incorporation fosters binding and activation of platelets. Fibrin thus is not an inert end product but partakes in further thrombus growth. Our findings help to elucidate the mechanism of thrombus growth and platelet adhesion under conditions of arterial shear rate.
引用
收藏
页码:35979 / 35986
页数:8
相关论文
共 50 条
  • [41] Distinct roles for platelet GPIba, PAR4 and fibrin in regulating thrombin-dependent recruitment of leukocytes to sites of vascular injury
    Kaplan, Z.
    Alwis, I
    Yuan, Y.
    Ghasemzadeh, M.
    Schoenwaelder, S. M.
    Ruggeri, Z. M.
    Jackson, S. P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 185 - 186
  • [42] Von Willebrand factor binding to heparin in von Willebrand disease
    Rastegar-Lari, G
    Legendre, P
    Ajzenberg, N
    Meyer, D
    Baruch, D
    THROMBOSIS AND HAEMOSTASIS, 1999, : 510 - 511
  • [43] Von Willebrand Factor and von Willebrand disease: prerequisite for diagnostic
    Fressinaud, Edith
    HEMATOLOGIE, 2014, 20 : 6 - 13
  • [44] von Willebrand disease and quantitative variation in von Willebrand factor
    Mohlke, KL
    Ginsburg, D
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 130 (03): : 252 - 261
  • [45] Von Willebrand factor plays a key role in thrombin generation in platelet rich plasma
    Keularts, IMLW
    Béguin, S
    Hamulyak, K
    Hemker, HC
    THROMBOSIS AND HAEMOSTASIS, 1999, : 509 - 509
  • [46] EFFECT OF THROMBIN (THR) ON FACTOR-VIII VON WILLEBRAND FACTOR (FVIII-VWF) PROTEIN
    SWITZER, MEP
    MCKEE, PA
    CIRCULATION, 1978, 58 (04) : 121 - 121
  • [47] Acquired von Willebrand syndrome: von Willebrand factor propeptide to von Willebrand factor antigen ratio predicts remission status
    Lee, Adrienne
    Sinclair, Gary
    Valentine, Karen
    James, Paula
    Poon, Man-Chiu
    BLOOD, 2014, 124 (05) : E1 - E3
  • [48] INHIBITION OF WILLEBRAND FACTOR IN VON WILLEBRAND DISEASE
    MARAGALL, S
    CASTILLO, R
    ORDINAS, A
    LIENDO, F
    RODRIGUEZ, M
    THROMBOSIS RESEARCH, 1979, 14 (2-3) : 495 - 500
  • [49] Optimizing therapy with factor VIII von Willebrand factor concentrates in von Willebrand disease
    Federici, AB
    Mannucci, PM
    HAEMOPHILIA, 1998, 4 : 7 - 10
  • [50] Pharmacokinetics of von Willebrand factor and factor VIII in canine von Willebrand disease and haemophilia A
    Stokol, T
    Trepanier, L
    Parry, BW
    Finnin, BC
    RESEARCH IN VETERINARY SCIENCE, 1997, 63 (01) : 23 - 27